Comparison of efficacy and pharmacoeconomics of two Helicobacter pylori eradication regimens in peptic ulcer disease

BACKGROUND: Helicobacter pylori, the cause of most peptic ulcer diseases, infects approximately 50% of the population worldwide. Indian data on cost and effectiveness of the standard first-line therapies for H. pylori eradication are scarce. Thus, the present study was aimed at comparing the cost an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubra Hussaini, Syeda Zaineb, Humaira Hussaini, Syeda Zaineb, Yasmeen, Ruheena, Unnisa, Bader, Syed, Aamir Ali Asgar, Khan, Md Nematullah, Hassan, Syed Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799951/
https://www.ncbi.nlm.nih.gov/pubmed/29430411
http://dx.doi.org/10.4103/picr.PICR_99_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799951/
https://www.ncbi.nlm.nih.gov/pubmed/29430411
http://dx.doi.org/10.4103/picr.PICR_99_16

Ejemplares similares